Treatment of infant formula with patiromer dose dependently decreases potassium concentration

Neil J Paloian1, Barbara Bowman2, Sharon M Bartosh2

  • 1Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI, 53792, USA. npaloian@wisc.edu.

Insights

Patiromer, a novel polymer, effectively reduces potassium in infant formula, offering a promising solution for managing hyperkalemia in infants with chronic kidney disease (CKD). This study demonstrates its potential for dietary potassium management.

Area of Science:

  • Nephrology
  • Pediatric Nutrition
  • Pharmaceutical Chemistry

Background:

  • Hyperkalemia is a serious risk for infants with chronic kidney disease (CKD).
  • Low-potassium infant formulas are available, but further dietary potassium restriction is often needed.
  • Patiromer, a calcium-based polymer, is a potential agent to reduce potassium in formulas, but efficacy data were lacking.

Purpose of the Study:

  • To evaluate the efficacy of patiromer in reducing potassium levels in infant formulas.
  • To assess the impact of varying patiromer doses and treatment durations on formula composition.
  • To investigate changes in other key electrolytes (calcium, sodium, magnesium, phosphorus) following patiromer treatment.

Main Methods:

  • Patiromer was added at different doses to two standard infant formulas (Similac Advance and Similac PM 60/40).
  • Potassium, calcium, sodium, magnesium, and phosphorus levels were measured at baseline and at 30 minutes, 60 minutes, and 24 hours post-administration.
  • Dose-dependent effects and time-course of ion exchange were analyzed.

Main Results:

  • Patiromer significantly decreased potassium concentrations in both formulas in a dose-dependent manner.
  • The most substantial potassium reduction occurred within 30 minutes of treatment.
  • Calcium levels increased dose-dependently, as expected, with minor changes observed in magnesium, sodium, and phosphorus.

Conclusions:

  • Pre-treatment of infant formula with patiromer effectively lowers potassium levels.
  • The ion-exchange process is rapid, with significant effects seen within 30 minutes.
  • Patiromer shows promise as a novel therapeutic option for managing hyperkalemia in infants with CKD.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
Chemical Formulas02:52

Chemical Formulas

A chemical formula presents information about the proportions of atoms constituting a particular chemical compound or molecule, mainly using symbols of elements and numbers. At times other symbols, such as dashes, parentheses, brackets, commas, plus, and minus signs, are also used. A chemical formula can be one of three types – molecular, empirical, and structural.
61.1K
The Integrated Rate Law: The Dependence of Concentration on Time02:39

The Integrated Rate Law: The Dependence of Concentration on Time

While the differential rate law relates the rate and concentrations of reactants, a second form of rate law called the integrated rate law relates concentrations of reactants and time. Integrated rate laws can be used to determine the amount of reactant or product present after a period of time or to estimate the time required for a reaction to proceed to a certain extent. For example, an integrated rate law helps determine the length of time a radioactive material must be stored for its...
41.1K
Molecular Compounds: Formulas and Nomenclature03:10

Molecular Compounds: Formulas and Nomenclature

Molecular compounds or covalent compounds result when atoms share electrons to form covalent bonds. Since there is no electron transfer, molecular compounds do not contain ions; instead, they consist of discrete, neutral molecules. 
55.4K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
658
Ionic Compounds: Formulas and Nomenclature03:34

Ionic Compounds: Formulas and Nomenclature

An element composed of atoms that readily lose electrons (a metal) can react with an element composed of atoms that readily gain electrons (a nonmetal) to produce ions through complete electron transfer. The compound formed by this transfer is stabilized by the electrostatic attractions (ionic bonds) between the oppositely charged ions.
86.4K